Khattab, E.; Kyriakou, M.; Leonidou, E.; Sokratous, S.; Mouzarou, A.; Myrianthefs, M.M.; Kadoglou, N.P.E.
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives. Pharmaceuticals 2025, 18, 134.
https://doi.org/10.3390/ph18010134
AMA Style
Khattab E, Kyriakou M, Leonidou E, Sokratous S, Mouzarou A, Myrianthefs MM, Kadoglou NPE.
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives. Pharmaceuticals. 2025; 18(1):134.
https://doi.org/10.3390/ph18010134
Chicago/Turabian Style
Khattab, Elina, Michaelia Kyriakou, Elena Leonidou, Stefanos Sokratous, Angeliki Mouzarou, Michael M. Myrianthefs, and Nikolaos P. E. Kadoglou.
2025. "Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives" Pharmaceuticals 18, no. 1: 134.
https://doi.org/10.3390/ph18010134
APA Style
Khattab, E., Kyriakou, M., Leonidou, E., Sokratous, S., Mouzarou, A., Myrianthefs, M. M., & Kadoglou, N. P. E.
(2025). Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives. Pharmaceuticals, 18(1), 134.
https://doi.org/10.3390/ph18010134
